Abstract

Human immunodeficiency virus type 1 (HIV-1) infection is a chronic condition, where viral DNA integrates into the genome. Latently infected cells form a persistent, heterogeneous reservoir that at any time can reactivate the integrated HIV-1. Here we confirmed that latently infected cells from HIV-1 positive study participants exhibited active HIV-1 transcription but without production of mature spliced mRNAs. To elucidate the mechanisms behind this we employed primary HIV-1 latency models to study latency establishment and maintenance. We characterized proviral transcription and chromatin development in cultures of resting primary CD4+ T-cells for four months after ex vivo HIV-1 infection. As heterochromatin (marked with H3K9me3 or H3K27me3) gradually stabilized, the provirus became less accessible with reduced activation potential. In a subset of infected cells, active marks (e.g. H3K27ac) and elongating RNAPII remained detectable at the latent provirus, despite prolonged proviral silencing. In many aspects, latent HIV-1 resembled an active enhancer in a subset of resting cells. The enhancer chromatin actively promoted latency and the enhancer-specific CBP/P300-inhibitor GNE049 was identified as a new latency reversal agent. The division of the latent reservoir according to distinct chromatin compositions with different reactivation potential enforces the notion that even though a relatively large set of cells contains the HIV-1 provirus, only a discrete subset is readily able to reactivate the provirus and spread the infection.

Highlights

  • Once human immunodeficiency virus type 1 (HIV-1) infects a cell, typically an activated CD4+ T-lymphocyte, the viral genome can integrate into the host chromosome as a provirus

  • This information is integrated in the host cell as a provirus

  • Transcription over the provirus isolated from cells from person living with HIV (PLWH) under ART

Read more

Summary

Introduction

Once human immunodeficiency virus type 1 (HIV-1) infects a cell, typically an activated CD4+ T-lymphocyte, the viral genome can integrate into the host chromosome as a provirus. The viral sequence is packaged into chromatin, and in a subset of cells, as the cell returns to quiescence, the proviral chromatin becomes condensed and silenced together with large portions of host chromatin [1,2]. The reservoir of rare cells harboring a latent intact provirus, 1 in 105–106 circulating CD4+ T-cells [3,4], is considered the main obstacle for curing HIV-1/AIDS. To the best of our current knowledge, indistinguishable from uninfected cells. The virus escapes the immune system and the actions of current anti-retroviral drugs. A means for identifying this functional reservoir would represent a milestone in clinical practice

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call